Ongoing shortages of popular weight loss and diabetes drugs in the U.S. have spurred fierce competition between established ...

Shares of BioAge Labs (BIOA), a biopharmaceutical company focused on obesity drugs, opened 25% above its initial public ...

With 890 million people affected globally and 42% of American adults classified as obese, the allure of a "miracle" weight ...

Semaglutide – a key ingredient in Ozempic and Wegovy – was associated with a lower risk of opioid overdose in patients with Type 2 diabetes and opioid use disorder, research shows.

An emerging market for compounded weight loss injections that mimic brand-name drugs such as Ozempic, Wegovy, Mounjaro and ...

Patients with obesity and hidradenitis suppurative treated with Wegovy experienced reduced flare-ups and improved quality of ...